Annual report pursuant to Section 13 and 15(d)

Balance Sheets

v3.22.1
Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 836,874 $ 47,090
Prepaid expenses 774,677
Total current assets 1,611,551 47,090
Investments held in Trust Account 862,549,773
Deferred offering costs associated with initial public offering 282,875
Total Assets 864,161,324 329,965
Current liabilities:    
Accounts payable 8,047 117,911
Accrued expenses 162,917 21,614
Franchise tax payable 200,045 609
Note payable – related party 170,000
Total current liabilities 371,009 310,134
Derivative warrant liabilities 30,268,330
Deferred underwriting commissions 30,187,500
Promissory note – related party 1,392,950
Deferred legal costs 957,588
Total liabilities 63,177,377 310,134
Commitments and Contingencies
Class A common stock subject to possible redemption, $0.0001 par value; 86,250,000 and -0- shares issued and outstanding at $10.00 per share redemption price at December 31, 2021 and December 31, 2020, respectively 862,500,000
Stockholders’ Equity (Deficit):    
Preferred stock, $0.0001 par value; 3,000,000 shares authorized; none issued or outstanding
Class A common stock, $0.0001 par value; 300,000,000 shares authorized ; no non-redeemable shares issued or outstanding at December 31, 2021 and 2020
Class B common stock, $0.0001 par value; 30,000,000 shares authorized; 21,562,500 shares issued and outstanding at December 31, 2021 and 2020 2,156 2,156
Additional paid-in capital 22,844
Accumulated deficit (61,518,209) (5,169)
Total stockholders’ equity (deficit) (61,516,053) 19,831
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit) $ 864,161,324 $ 329,965